Management ChangeJul 24, 2026, 08:41 AM
Vir Bio CFO Jason O’Byrne Departs; Interim CFO Appointed
AI Summary
Vir Biotechnology announced that Jason O’Byrne, Executive Vice President and Chief Financial Officer, will step down from his role effective August 3, 2026, to pursue another opportunity. His resignation was not due to any disagreement with the company. Vir Bio has initiated a search for his successor. Additionally, the Board of Directors appointed Brent Sabatini, Senior Vice President and Chief Accounting Officer, as interim principal financial officer, also effective August 3, 2026. Mr. Sabatini, who has over two decades of relevant experience, will not receive any additional compensation for this interim function.
Key Highlights
- Jason O’Byrne, EVP and CFO, will step down from his role.
- Mr. O’Byrne's departure is effective August 3, 2026.
- Brent Sabatini appointed interim principal financial officer.
- Mr. Sabatini's interim role is effective August 3, 2026.
- Mr. Sabatini has served as SVP and Chief Accounting Officer since February 2023.
- Mr. Sabatini will not receive additional compensation for the interim role.
Price Impact
More from VIR